Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics.

作者: Kristine L. Witt , Patricia G. Moorman , Olga Kovalchuk , Nina Holland , Gladys Block

DOI: 10.1002/EM.20607

关键词:

摘要: This manuscript presents an overview of a symposium held at the 2009 annual meeting Environmental Mutagen Society (EMS) in St. Louis, MO. The was sponsored by Women (WEMS) special interest group, and it covered current molecular genetics technologies their impact on diagnosis treatment diseases that primarily or differentially affect women. Four speakers presented groundbreaking new information from such areas as cancer genetics, gene-environment interactions, epigenetics, DNA repair, epidemiology. Although primary focus symposium, other health issues obesity cardiovascular disease were addressed. rapid evolution genomic discussed this should provide tools to explore some critical questions raised research projects described article. demonstrates EMS provides forum for presentation, discussion, extension data generated investigators featured article researchers engaged study mechanisms interactions women's health. Environ. Mol. Mutagen., 2010. © 2010 Wiley-Liss, Inc.

参考文章(37)
C Coudray, A Favier, A M Roussel, J Arnaud, F Mainard, Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). Journal of The American College of Nutrition. ,vol. 16, pp. 584- 591 ,(1997)
Nicholas Turner, Andrew Tutt, Alan Ashworth, Hallmarks of 'BRCAness' in sporadic cancers Nature Reviews Cancer. ,vol. 4, pp. 814- 819 ,(2004) , 10.1038/NRC1457
Jennifer Permuth-Wey, Thomas A. Sellers, Epidemiology of ovarian cancer. Methods of Molecular Biology. ,vol. 472, pp. 413- 437 ,(2009) , 10.1007/978-1-60327-492-0_20
Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko, Alexander Miron, Qing Sheng, Guilan Li, Henna Mattila, Daphne W Bell, Daniel A Haber, Mervi Grip, Mervi Reiman, Arja Jukkola-Vuorinen, Aki Mustonen, Juha Kere, Lauri A Aaltonen, Veli-Matti Kosma, Vesa Kataja, Ylermi Soini, Ronny I Drapkin, David M Livingston, Robert Winqvist, None, A recurrent mutation in PALB2 in Finnish cancer families Nature. ,vol. 446, pp. 316- 319 ,(2007) , 10.1038/NATURE05609
Feng Zhang, Jianglin Ma, Jiaxue Wu, Lin Ye, Hong Cai, Bing Xia, Xiaochun Yu, PALB2 links BRCA1 and BRCA2 in the DNA-damage response Current Biology. ,vol. 19, pp. 524- 529 ,(2009) , 10.1016/J.CUB.2009.02.018
Karen Huen, Kim Harley, Asa Bradman, Brenda Eskenazi, Nina Holland, Longitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypes Toxicology and Applied Pharmacology. ,vol. 244, pp. 181- 189 ,(2010) , 10.1016/J.TAAP.2009.12.031
Aurélie Catteau, Joanna R. Morris, BRCA1 methylation: a significant role in tumour development? Seminars in Cancer Biology. ,vol. 12, pp. 359- 371 ,(2002) , 10.1016/S1044-579X(02)00056-1
Joellen M. Schildkraut, Patricia G. Moorman, Susan Halabi, Brian Calingaert, Jeffrey R. Marks, Andrew Berchuck, Analgesic drug use and risk of ovarian cancer. Epidemiology. ,vol. 17, pp. 104- 107 ,(2006) , 10.1097/01.EDE.0000190538.55645.F8
Peter A. Fasching, Simon Gayther, Leigh Pearce, Joellen M. Schildkraut, Ellen Goode, Falk Thiel, Georgia Chenevix-Trench, Jenny Chang-Claude, Shan Wang-Gohrke, Susan Ramus, Paul Pharoah, Andrew Berchuck, Role of genetic polymorphisms and ovarian cancer susceptibility Molecular Oncology. ,vol. 3, pp. 171- 181 ,(2009) , 10.1016/J.MOLONC.2009.01.008
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Lesley McGuffog, Sandra Hanks, D Gareth Evans, Diana Eccles, Breast Cancer Susceptibility Collaboration (UK), Douglas F Easton, Michael R Stratton, None, PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nature Genetics. ,vol. 39, pp. 165- 167 ,(2007) , 10.1038/NG1959